Rhumbline Advisers Raises Stock Position in Privia Health Group, Inc. (NASDAQ:PRVA)

Rhumbline Advisers lifted its stake in Privia Health Group, Inc. (NASDAQ:PRVA) by 1.3% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 287,200 shares of the company’s stock after buying an additional 3,658 shares during the period. Rhumbline Advisers’ holdings in Privia Health Group were worth $5,615,000 at the end of the most recent quarter.

Other hedge funds and other institutional investors have also recently bought and sold shares of the company. Nordea Investment Management AB boosted its stake in Privia Health Group by 33.1% in the fourth quarter. Nordea Investment Management AB now owns 349,773 shares of the company’s stock valued at $6,953,000 after acquiring an additional 86,910 shares in the last quarter. Victory Capital Management Inc. increased its position in shares of Privia Health Group by 402.9% during the third quarter. Victory Capital Management Inc. now owns 179,049 shares of the company’s stock worth $3,260,000 after purchasing an additional 143,446 shares in the last quarter. Franklin Resources Inc. lifted its holdings in shares of Privia Health Group by 2.2% in the 3rd quarter. Franklin Resources Inc. now owns 1,300,240 shares of the company’s stock valued at $23,092,000 after purchasing an additional 28,480 shares during the last quarter. Barclays PLC boosted its position in shares of Privia Health Group by 240.3% in the 3rd quarter. Barclays PLC now owns 224,018 shares of the company’s stock valued at $4,079,000 after purchasing an additional 158,188 shares during the period. Finally, JPMorgan Chase & Co. boosted its position in shares of Privia Health Group by 8.4% in the 3rd quarter. JPMorgan Chase & Co. now owns 188,384 shares of the company’s stock valued at $3,430,000 after purchasing an additional 14,641 shares during the period. 94.48% of the stock is currently owned by institutional investors and hedge funds.

Privia Health Group Trading Up 5.8 %

Shares of PRVA opened at $25.46 on Friday. The stock’s 50 day moving average is $22.30 and its two-hundred day moving average is $20.55. Privia Health Group, Inc. has a twelve month low of $15.92 and a twelve month high of $26.04. The firm has a market capitalization of $3.06 billion, a PE ratio of 254.63, a P/E/G ratio of 3.47 and a beta of 0.87.

Wall Street Analyst Weigh In

PRVA has been the topic of several research analyst reports. Barclays lifted their price target on Privia Health Group from $19.00 to $21.00 and gave the stock an “equal weight” rating in a research report on Friday, November 8th. JPMorgan Chase & Co. lifted their target price on shares of Privia Health Group from $27.00 to $28.00 and gave the company an “overweight” rating in a report on Friday, November 29th. Needham & Company LLC initiated coverage on shares of Privia Health Group in a research report on Friday, January 10th. They issued a “buy” rating and a $25.00 price target for the company. Macquarie initiated coverage on shares of Privia Health Group in a research report on Monday, December 16th. They set an “outperform” rating and a $25.00 price objective on the stock. Finally, Truist Financial upped their target price on shares of Privia Health Group from $24.00 to $27.00 and gave the company a “buy” rating in a report on Friday, November 8th. One investment analyst has rated the stock with a hold rating, fourteen have issued a buy rating and two have issued a strong buy rating to the company’s stock. According to MarketBeat, Privia Health Group currently has a consensus rating of “Buy” and an average target price of $25.19.

Privia Health Group Company Profile

Privia Health Group, Inc operates as a national physician-enablement company in the United States. The company collaborates with medical groups, health plans, and health systems to optimize physician practices, enhance patient experiences, and reward doctors for delivering care in-person and virtual settings.